Cargando…
Serine-arginine splicing factor 2 promotes oesophageal cancer progression by regulating alternative splicing of interferon regulatory factor 3
OBJECTIVE: Often, alternative splicing is used by cancer cells to produce or increase proteins that promote growth and survival through alternative splicing. Although RNA-binding proteins are known to regulate alternative splicing events associated with tumorigenesis, their role in oesophageal cance...
Autores principales: | Wei, Ziqing, Wang, Yuyao, Ma, Wenyuan, Xing, Wenqing, Lu, Peng, Shang, Zhijie, Li, Feng, Li, Huiyu, Wang, Yuxuan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10281462/ https://www.ncbi.nlm.nih.gov/pubmed/37335045 http://dx.doi.org/10.1080/15476286.2023.2223939 |
Ejemplares similares
-
Serine/arginine-rich splicing factors: the bridge linking alternative splicing and cancer
por: Zheng, Xiang, et al.
Publicado: (2020) -
Towards understandings of serine/arginine-rich splicing factors
por: Li, Dianyang, et al.
Publicado: (2023) -
A serine–arginine-rich (SR) splicing factor modulates alternative splicing of over a thousand genes in Toxoplasma gondii
por: Yeoh, Lee M., et al.
Publicado: (2015) -
Myelodysplasia-associated mutations in serine/arginine-rich splicing factor SRSF2 lead to alternative splicing of CDC25C
por: Skrdlant, Lindsey, et al.
Publicado: (2016) -
Splicosomal and serine and arginine-rich splicing factors as targets for TGF-β
por: Hallgren, Oskar, et al.
Publicado: (2012)